SOUTH SAN FRANCISCO, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (NASDAQ:PLRX), a clinical-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today announced three presentations at the upcoming 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) taking place November 1 - 5, 2023 at the San Diego Convention Center in San Diego, California.
Abstract Number 1467
Date and Time: Friday, November 3rd 9:00 a.m. PT
Location: Poster Hall (Exhibit Hall B)
Abstract Number 714
Date and Time: Saturday, November 4th 9:00 a.m. PT
Location: Poster Hall (Exhibit Hall B)
Abstract Number 464
Date and Time: Saturday, November 4th 9:00 a.m. PT
Location: Poster Hall (Exhibit Hall B)
Posters will be made available on the Publications page of the Pliant website.
About Pliant Therapeutics, Inc.
Pliant Therapeutics is a clinical-stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases. Pliant's lead product candidate, ...